The diabetes drug called liraglutide, marketed as Victoza, can reverse a common and serious complication of diabetes, according to a new study. This is good news for anyone who is already taking it or Byetta or Bydureon to manage blood glucose.
This complication goes by the mouthful of a name “non-alcoholic steatohepatitis,” or NASH, which is inflammation of the liver, which a buildup of fat in the liver causes. Non-alcoholic fatty liver disease, or NAFLD, which half to 70 percent of all people with type 2 diabetes have, can lead to NASH.